Cineworld posts H1 loss as it mulls US listing

Cineworld posted an interim operating loss of $208.9m as the Covid pandemic forced the closure of cinemas in the opening months of the year and a limited number of films were produced, but said trading since reopening had been "encouraging".

Source: Sharecast

The cinema chain on Thursday added that it was considering a listing of itself or a partial listing of its movie chain Regal in the US, its biggest market.

Operating losses in the six months to June 30 were reduced by asset impairment reversals of $95.6m resulting from lease modifications and were sharply narrower compared to the same period in 2020 when the group posted a loss of $1.34bn.

Group revenues fell to $292.8m from $712.4m and adjusted core earnings showed a loss of $21.1m from a profit of $53m when Covid-enforced closures hit the leisure industry hard. Admissions plunged 70.3% to 14.1m.

Cash burn was around $45m a month, supported by positive working capital in June. As of June 2021, the group had cash of $436.5m, which was strengthened by an additional term loan with principal value of $200m raised in July.

“In view of the situation related to Covid-19, the studios entered into various experiments which we believe ultimately will lead to a situation whereby there is a theatrical window but it is shorter than in the past and dependent on the theatrical revenue potential of the movie itself,” the company said.

“Currently, movies are being released with windows that are anywhere between 0-60 days. We expect that by 2022, the window will stabilize to somewhere between 20 and 60 days, but subject to each movie’s potential.”

Cineworld said it was encouraged by an upcoming film release slate the includes the four new Marvel movies as well as ‘Top Gun Maverick’ , a new Bond film, the fourth in the ‘Matrix’ series and ‘Dune’. The group operates in 10 countries with 9,269 screens globally.

Chief executive Mooky Greidinger said trading had been encouraging since the chain started to re-open sites in April.

"We expect this progress to continue as vaccination programs continue to successfully roll out and as restrictions ease into the second half of 2021. The strong film slate, in particular for Q4, gives us great confidence in our ability to continue to rebound strongly."

“I am confident that the business is in a strong position to execute its strategy and deliver a return to growth as we recover from the pandemic and capitalise on the forthcoming strong film slate alongside clear pent-up consumer demand,” he said.

Harry Barnick, analyst at Third Bridge, said "some estimates suggest that box office revenues will be 10% lower post-covid permanently as customers have grown accustomed to watching films at home, studios shortened the theatrical window and exhibitors have permanently closed the curtains on unprofitable cinemas".

"Cineworld is dependent on blockbuster films enticing customers back to the cinema. It must also pivot to new revenue streams: less Hollywood, more arthouse and alternative content."

"Cineworld's leverage has skyrocketed during covid and its debt burden will be an additional challenge through the recovery period."

N/A

Isin: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

Logo Allfunds

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

FE fundinfo Logo

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

Refinitiv Logo

© 2025 Refinitiv, an LSEG business. All rights reserved.